The effect of E-N-l-trimethyllysine (TML) on the humoral and cellular immune response

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

E-N-l-Trimethyllysine glutamate (TML) influences the humoral and cellular immune response of mice. Chronic pre- and post-treatment (100 mg/kg/day, 5 times) transitionally increased the anti-SRBC haemagglutinin titre of female CBA mice. After 400 r whole body irradiation, TML treatment accelerated the normalization of the haemagglutinin level. TML treatment prolonged the life-span of BDF1 hybrid mice that had first been immunized and then inoculated with L1210 cells. TML diminished the delayed type hypersensitivity mice and dosse-dependently decreased the spontaneous (SLMC) and antibody-dependent (ADCC) cytotoxicity of healthy human lymphocytes, in vitro. As a low molecular weight immunomodulant, TML may also be considered as a therapeutic tool.

Original languageEnglish
Pages (from-to)503-507
Number of pages5
JournalAgents and Actions
Volume12
Issue number4
DOIs
Publication statusPublished - 1982

Fingerprint

Hemagglutinins
Humoral Immunity
Cellular Immunity
Lymphocytes
Cytotoxicity
Glutamic Acid
Molecular weight
Irradiation
Antibodies
Antibody-Dependent Cell Cytotoxicity
Therapeutics
Inbred CBA Mouse
Whole-Body Irradiation
Delayed Hypersensitivity
Molecular Weight
trimethyllysine

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Toxicology

Cite this

The effect of E-N-l-trimethyllysine (TML) on the humoral and cellular immune response. / Elek, G.; Láng, I.; Szende, B.; Lapis, K.

In: Agents and Actions, Vol. 12, No. 4, 1982, p. 503-507.

Research output: Contribution to journalArticle

@article{b71a82274d1349ef8cbe8ed1c8fb2d61,
title = "The effect of E-N-l-trimethyllysine (TML) on the humoral and cellular immune response",
abstract = "E-N-l-Trimethyllysine glutamate (TML) influences the humoral and cellular immune response of mice. Chronic pre- and post-treatment (100 mg/kg/day, 5 times) transitionally increased the anti-SRBC haemagglutinin titre of female CBA mice. After 400 r whole body irradiation, TML treatment accelerated the normalization of the haemagglutinin level. TML treatment prolonged the life-span of BDF1 hybrid mice that had first been immunized and then inoculated with L1210 cells. TML diminished the delayed type hypersensitivity mice and dosse-dependently decreased the spontaneous (SLMC) and antibody-dependent (ADCC) cytotoxicity of healthy human lymphocytes, in vitro. As a low molecular weight immunomodulant, TML may also be considered as a therapeutic tool.",
author = "G. Elek and I. L{\'a}ng and B. Szende and K. Lapis",
year = "1982",
doi = "10.1007/BF01965934",
language = "English",
volume = "12",
pages = "503--507",
journal = "Inflammation Research",
issn = "1023-3830",
publisher = "Birkhauser Verlag Basel",
number = "4",

}

TY - JOUR

T1 - The effect of E-N-l-trimethyllysine (TML) on the humoral and cellular immune response

AU - Elek, G.

AU - Láng, I.

AU - Szende, B.

AU - Lapis, K.

PY - 1982

Y1 - 1982

N2 - E-N-l-Trimethyllysine glutamate (TML) influences the humoral and cellular immune response of mice. Chronic pre- and post-treatment (100 mg/kg/day, 5 times) transitionally increased the anti-SRBC haemagglutinin titre of female CBA mice. After 400 r whole body irradiation, TML treatment accelerated the normalization of the haemagglutinin level. TML treatment prolonged the life-span of BDF1 hybrid mice that had first been immunized and then inoculated with L1210 cells. TML diminished the delayed type hypersensitivity mice and dosse-dependently decreased the spontaneous (SLMC) and antibody-dependent (ADCC) cytotoxicity of healthy human lymphocytes, in vitro. As a low molecular weight immunomodulant, TML may also be considered as a therapeutic tool.

AB - E-N-l-Trimethyllysine glutamate (TML) influences the humoral and cellular immune response of mice. Chronic pre- and post-treatment (100 mg/kg/day, 5 times) transitionally increased the anti-SRBC haemagglutinin titre of female CBA mice. After 400 r whole body irradiation, TML treatment accelerated the normalization of the haemagglutinin level. TML treatment prolonged the life-span of BDF1 hybrid mice that had first been immunized and then inoculated with L1210 cells. TML diminished the delayed type hypersensitivity mice and dosse-dependently decreased the spontaneous (SLMC) and antibody-dependent (ADCC) cytotoxicity of healthy human lymphocytes, in vitro. As a low molecular weight immunomodulant, TML may also be considered as a therapeutic tool.

UR - http://www.scopus.com/inward/record.url?scp=0020453010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020453010&partnerID=8YFLogxK

U2 - 10.1007/BF01965934

DO - 10.1007/BF01965934

M3 - Article

C2 - 6817621

AN - SCOPUS:0020453010

VL - 12

SP - 503

EP - 507

JO - Inflammation Research

JF - Inflammation Research

SN - 1023-3830

IS - 4

ER -